Clinical Trial Update: Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating estrogen priming to enhance adjuvant chemotherapy in operable breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sudeep Gupta | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED